Samples,bcr_patient_barcode,bcr_patient_uuid,form_completion_date,prospective_collection,retrospective_collection,birth_days_to,gender,height_cm_at_diagnosis,weight_kg_at_diagnosis,race,ethnicity,history_other_malignancy,history_neoadjuvant_treatment,noninvasive_bladder_history,noninvasive_bladder_ca_tx_type,bcg_tx_90_days_prior_to_resection,bcg_tx_complete_response,bcg_tx_induction_courses_indicator,bcg_tx_maintenance_courses_indicator,bcg_complete_response_months,tumor_status,vital_status,last_contact_days_to,death_days_to,occupation_current,occupation_primary,occupation_primary_chemical_exposure,occupation_primary_industry,occupation_primary_years_worked,tobacco_smoking_history_indicator,tobacco_smoking_age_started,tobacco_smoking_year_stopped,tobacco_smoking_pack_years_smoked,family_history_cancer_relationship,family_history_cancer_type,radiation_treatment_adjuvant,pharmaceutical_tx_adjuvant,treatment_outcome_first_course,karnofsky_score,ecog_score,histologic_subtype,initial_pathologic_dx_year,age_at_diagnosis,age_at_diagnosis.1,method_initial_path_dx,method_initial_path_dx_other,ajcc_staging_edition,ajcc_tumor_pathologic_pt,lymphovascular_invasion,ajcc_nodes_pathologic_pn,lymph_nodes_examined_count,lymph_nodes_examined,lymph_nodes_examined_he_count,extracapsular_extension,extracapsular_extension_present,ajcc_metastasis_pathologic_pm,metastasis_site,metastatic_site_other,ajcc_pathologic_tumor_stage,incidental_prostate_cancer_indicator,ajcc_path_pt_incidental_prostate,new_tumor_event_dx_indicator,anatomic_neoplasm_subdivision,clinical_M,clinical_N,clinical_T,clinical_stage,days_to_initial_pathologic_diagnosis,extranodal_involvement,histological_type,icd_10,icd_o_3_histology,icd_o_3_site,informed_consent_verified,neoplasm_histologic_grade,patient_id,tissue_source_site,tumor_tissue_site,menopause_status,histologic_diagnosis_other,surgical_procedure_first,first_surgical_procedure_other,margin_status,surgery_for_positive_margins,surgery_for_positive_margins_other,margin_status_reexcision,axillary_staging_method,axillary_staging_method_other,micromet_detection_by_ihc,lymph_nodes_examined_ihc_count,metastasis_site_other,er_status_by_ihc,er_status_ihc_Percent_Positive,er_positivity_scale_used,er_ihc_score,er_positivity_scale_other,er_positivity_method,pr_status_by_ihc,pr_status_ihc_percent_positive,pr_positivity_scale_used,pr_positivity_ihc_intensity_score,pr_positivity_scale_other,pr_positivity_define_method,her2_status_by_ihc,her2_ihc_percent_positive,her2_ihc_score,her2_positivity_scale_other,her2_positivity_method_text,her2_fish_status,her2_copy_number,cent17_copy_number,her2_and_cent17_cells_count,her2_cent17_ratio,her2_and_cent17_scale_other,her2_fish_method,nte_er_status,nte_er_status_ihc__positive,nte_er_ihc_intensity_score,nte_er_positivity_other_scale,nte_er_positivity_define_method,nte_pr_status_by_ihc,nte_pr_status_ihc__positive,nte_pr_ihc_intensity_score,nte_pr_positivity_other_scale,nte_pr_positivity_define_method,nte_her2_status,nte_her2_status_ihc__positive,nte_her2_positivity_ihc_score,nte_her2_positivity_other_scale,nte_her2_positivity_method,nte_her2_fish_status,nte_her2_signal_number,nte_cent_17_signal_number,her2_cent17_counted_cells_count,nte_cent_17_her2_ratio,nte_cent17_her2_other_scale,nte_her2_fish_define_method,metastatic_tumor_indicator,site_of_primary_tumor_other,histologic_diagnosis,residual_tumor,cea_level_pretreatment,specimen_non_node_tumor_deposits,circumferential_resection_margin_crm,vascular_invasion_indicator,lymphovascular_invasion_indicator,perineural_invasion,microsatellite_instability,loci_tested_count,loci_abnormal_count,mismatch_rep_proteins_tested_by_ihc,mismatch_rep_proteins_loss_ihc,kras_gene_analysis_indicator,kras_mutation_found,kras_mutation_codon,braf_gene_analysis_indicator,braf_gene_analysis_result,history_other_malignancy.1,history_colon_polyps,colon_polyps_at_procurement_indicator,family_history_colorectal_cancer,age_at_initial_pathologic_diagnosis,history_lgg_dx_of_brain_tissue,performance_status_timing,anatomic_organ_subdivision,laterality,lymph_node_neck_dissection_indicator,lymph_node_dissection_method,lymph_node_dissection_method.1,p53_gene_analysis,egfr_amplification_status,extracapsular_spread_pathologic,tumor_grade,hpv_status_p16,hpv_status_ish,tobacco_smoking_year_started,alcohol_history_documented,alcohol_consumption_frequency,alcohol_consumption_per_day,sarcomatoid_features,sarcomatoid_percent_of_tumor,lymph_nodes_examined_positive,ajcc_metastasis_clinical_cm,ldh_level,serum_calcium_level,hemoglobin_level,platelet_count,white_cell_count,erythrocyte_sedimentation_rate,targeted_molecular_therapy,tumor_type,history_hematologic_disorder,history_neoadjuvant_hydroxyurea_tx,hydroxyurea_tx_days,total_dose,history_exposure_leukemogenic_agents,history_chemical_exposure_other,performance_status_other_timing,cells_used_for_analysis_source,percent_blasts_peripheral_blood,fab_category,cyto_and_immuno_test_performed,cyto_and_immuno_test_percentage,percent_cellularity,wbc_24hr_of_banking,hemoglobin_24hr_of_banking,hematocrit_24hr_of_banking,platelet_count_preresection,blast_count,promyelocytes_count,myelocytes_24hr_of_banking,metamyelocytes_24hr_of_banking,bands_24hr_of_banking,segs_24hr_of_banking,basophils_count,basophils_count.1,lymphocytes_count,monocytes_count,prolymphocytes_24hr_of_banking,promonocytes_24hr_of_banking,abnormal_lymphocyte_percent,cytogenetics_testing_performed,metaphases_count,cyto_risk_group,cytogenetic_abnormality_type,cyto_abnormality_type_other,fish_performed_indicator,fish_abnormality_detected,fish_performed_outcome,molecular_studies_others_performed,molecular_analysis_method_type,type_of_analysis_other,molecular_abnormality_detected,molecular_abnormality_results,molecular_abnormality_percent,FISH_test_component,atra_exposure,diff_count_not_present_reason,pharmaceutical_tx_total_dose_units,steroid_therapy_administered,tumor_site,supratentorial_localization,history_ionizing_rt_to_head,history_seizures,history_headaches,symp_changes_mental_status,symp_changes_visual,symp_changes_sensory,symp_changes_motor_movement,related_symptom_first_present,first_symptom_longest_duration,history_asthma,history_eczema,histor_hay_fever,history_dust_mold_allergy,asthma_eczema_allergy_first_dx,allergy_food_dx_indicator,allergy_food_dx_type,allergy_food_dx_age,allergy_animals_insects_dx_indicator,allergy_animals_insects_dx_type,allergy_animals_insects_dx_age,history_neoadjuvant_steroid_tx,history_neoadjuvant_medication,family_history_cancer_indicator,family_history_brain_tumor,idh1_mutation_test_indicator,idh1_mutation_test_method,idh1_mutation_found,inherited_genetic_syndrome_indicator,inherited_genetic_syndrome_specified,performance_status_days_to,family_history_cancer_number_relatives,history_hepato_carcinoma_risk_factors,other_hepato_carcinoma_risk_factors,ablation_embolization_tx_adjuvant,definitive_surgical_procedure,surgical_procedure_other,vascular_invasion,child_pugh_classification,alpha_fetoprotien_at_procurement,alpha_fetoprotien_norm_range_lower,alpha_fetoprotien_norm_range_upper,platelet_norm_range_lower,platelet_norm_range_upper,prothrombin_time_INR_at_procurement,prothrom_time_INR_norm_range_lower,prothrombin_time_norm_range_upper,serum_albumin_preresection,serum_albumin_norm_range_lower,serum_albumin_norm_range_upper,bilirubin_total,bilirubin_total_norm_range_lower,bilirubin_total_norm_range_upper,creatinine_level_preresection,creatinine_norm_range_lower,creatinine_norm_range_upper,ishak_fibrosis_score,hepatic_inflammation_adj_tissue,days_to_definitive_surgical_procedure_performed,year_of_initial_pathologic_diagnosis,location_lung_parenchyma,histologic_diagnosis.1,ajcc_tumor_clinical_ct,ajcc_nodes_clinical_cn,ajcc_clinical_tumor_stage,pulmonary_function_test_indicator,fev1_percent_ref_prebroncholiator,fev1_percent_ref_postbroncholiator,fev1_fvc_ratio_prebroncholiator,fev1_fvc_ratio_postbroncholiator,carbon_monoxide_diffusion_dlco,kras_mutation_identified_type,egfr_mutation_status,egfr_mutation_identified_type,eml4_alk_translocation_status,eml4_alk_translocation_variant,eml4_alk_analysis_type,anatomic_neoplasm_subdivision_other,jewish_religion_heritage_indicator,residual_disease_largest_nodule,pathologic_M,pathologic_N,pathologic_T,pathologic_stage,system_version,zone_of_origin,gleason_pattern_primary,gleason_pattern_secondary,gleason_score,gleason_pattern_tertiary,tumor_level,days_to_bone_scan,bone_scan_results,ct_scan_ab_pelvis_indicator,days_to_ct_scan_ab_pelvis,ct_scan_ab_pelvis_results,mri_at_diagnosis,days_to_mri,mri_results,cause_of_death,cause_of_death_source,days_to_psa_most_recent,psa_most_recent_results,biochemical_recurrence_indicator,days_to_biochemical_recurrence_first,initial_pathologic_diagnosis_method,primary_melanoma_known_dx,primary_multiple_at_dx,primary_at_dx_count,breslow_thickness_at_diagnosis,clark_level_at_diagnosis,primary_melanoma_tumor_ulceration,primary_melanoma_mitotic_rate,submitted_tumor_dx_days_to,submitted_tumor_site,submitted_tumor_site.1,metastatic_tumor_site,primary_melanoma_skin_type,history_neoadjuvant_tx_type,ifn_tx_90_days_prior_to_resection,new_tumor_event_prior_to_bcr_tumor,new_tumor_event_melanoma_count,tumor_tissue_site_other,tumor_sample_procurement_country,tumor_sample_procurement_country.1,cancer_procurement_city,history_reflux_disease_indicator,antireflux_treatment,antireflux_treatment_type,barretts_esophagus,h_pylori_infection,family_history_of_stomach_cancer,number_of_relatives_with_stomach_cancer,number_of_lymphnodes_positive_by_ihc,history_thyroid_disease,history_thyroid_disease_other,family_history_thyroid_cancer,history_radiation_exposure,tumor_focality,tumor_size_width,tumor_size_width.1,tumor_size_width.2,lymph_nodes_preop_imaging,lymph_nodes_preop_imaging_type,extrathyroidal_extension,metastatic_dx_confirmed_by,metastatic_dx_confirmed_by_other,genotypic_analysis_detected,braf_mutation_result,ras_mutation_result,ret_ptc_rearrangement_result,genotypic_analysis_results_other,clinical_status_within_3_mths_surgery,i_131_radiation_first_tx_method,i_131_radiation_first_tx_dose,i_131_radiation_subsequent_tx,i_131_radiation_tx_cumulative_dose,radiation_therapy_xrt_method_prep,radiation_therapy_xrt_dose,radiation_therapy_xrt_sensitizers,genotyping_results_gene_mutation_not_reported_reason,history_menopausal_hormone_therapy,history_hormonal_contraceptives_use,history_tamoxifen_use,hypertension_diagnosis,diabetes_diagnosis_indicator,pregnancies_full_term_count,history_colorectal_cancer,surgical_approach_at_diagnosis,peritoneal_washing,tumor_invasion_percent,lymph_nodes_pelvic_examined_count,lymph_nodes_pelvic_pos__by_he,lymph_nodes_pelvic_pos_by_ihc,lymph_nodes_pelvic_pos_total,lymph_nodes_aortic_examined_count,lymph_nodes_aortic_pos_by_he,lymph_nodes_aortic_pos_by_ihc,lymph_nodes_aortic_pos_total
